Who is eligible for MyTrack™ Myeloma?

Patients with newly diagnosed myeloma, or patients at relapse, are eligible for MyTrack™ Myeloma. We would recommend to include patients, and consider patients for this pathway, who are planned to undergo a treatment that has a high response rate, a high MRD negativity rate, particularly. It's important to think about enrolling the patient before the start of treatment, so that we have tumour cells available to determine the tumour characteristics, but also to determine the specifications for the tumour tracking with the MRD test later on.